Tech Company Financing Transactions
Lyric Pharmaceuticals Funding Round
RiverVest Venture Partners participated in a $3 million funding round for Lyric Pharmaceuticals. The funding round was announced on 3/31/2016.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$3,001,000
Round
Undisclosed
Investors
RiverVest Venture Partners (Niall O'Donnell)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
601 Gateway Blvd. 1020
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Wurtman
Chief Financial Officer
Dana McGowan
Chief Marketing Officer
Scott Harris
Vice President
Scott Chadwick
Vice President
Kevin Kaster
VP - Bus. Development
Joyce James
VP - Operations
Randy Brown
VP - Regulatory Affairs
Meredith Brown-Tuttle
Browse more venture capital transactions:
Prev: 3/31/2016: VRChat venture capital transaction
Next: 3/31/2016: Marxent Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs